Experience in COVID-19 in hospitalized patients in pediatric critical units during pandemic period
Experiencia en COVID-19 en pacientes hospitalizados en unidades de paciente crítico pediátrico durante el periodo pandémico
Author
Wegner Araya, Adriana
Céspedes Fernández, Pamela
Astudillo Paredes, Patricio
Diettes González, Adriana
Díaz Rubio, Franco
Scheu Goncalves, Christian
Chauriye Kuncar, Verónica
Gaete Amenábar, Tomás
Zamora Astudillo, Marta
Acuña Aguirre, Carlos
Drago Thibaut, Michele
Monreal Eloaiza, Víctor
Lapadula Amelina, Michelangelo
Pietroboni Fuster, Pietro
Varela Ortiz, Javier
Gallardo Martínez, Alena
Scheuch Ruiz, Karin
Manen Chinchón, Andrés
Villarroel Carreño, María José
Verscheure Peralta, Felipe
Maldonado Valenzuela, Blanca
Meyer Flores, Matías
Full text
http://www.revistachilenadepediatria.cl/index.php/rchped/article/view/452710.32641/andespediatr.v94i5.4527
Abstract
Objectives: To characterize the COVID-19 disease profile in Chilean children hospitalized in pediatric intensive care units (PICU) and to evaluate risk factors associated with severe COVID-19.Patients and Method: A multicenter prospective cohort study with patients 0-18 years of age with confirmed SARS-CoV-2 hospitalized in PICU. Clinical, laboratory, imaging, and therapeutic variables were recorded. We compared ”mild/moderate COVID-19” with ”severe COVID-19” using median with interquartile range (IQR), Mann-Whitney U test, two-tailed Fisher’s test, and forward binary multivariate analysis to adjust variables for “severe COVID-19”. A p < 0.05 was considered significant.Results: From 16 PICUs, 219 patients were recruited, 55.3% were male, with a median age of 86 months (IQR: 13.5-156). The most frequent comorbidities were obesity and respiratory diseases. Overall mortality was 3.6%. “Severe COVID-19” (26.5%) showed more leukopenia, lymphopenia, increased inflammatory parameters, and altered organ function (p < 0.05). It also developed more sepsis/shock, ARDS, and organ dysfunction, requiring more hemodynamic, anti-inflammatory, anticoagulation, and antibiotic therapy, with a longer stay in the PICU/hospital (p < 0.05), and 13.8% of mortality. Risk factors associated with “severe COVID-19” were shock on admission to the PICU [aOR 28.44 (95%CI 10.45-77.4)], obesity [aOR 3.55 (95%CI 1.3-9.6)], consolidation [aOR 3.1 (95%CI 1.1 -8.7)], atelectasis [aOR: 8.7 (95%CI 1.17-64.3)], stress dose of corticosteroids [aOR 7.7 (95%CI 1.9-30.6)], early antibiotic therapy [aOR: 12.02 (95%CI 1.11-130.02)], acquired/congenital immunodeficiency [aOR: 19.2 (95%CI: 1.19-321)], and oncological pathology [aOR 10.7 (95%CI 2.14-47.8)].Conclusion: In this Chilean pediatric cohort, most patients with COVID-19 admitted to de PICU were male, of school age, with associated comorbidity. Risk factors for developing severe COVID-19 were the presence of comorbidities such as acquired/congenital immunodeficiency, oncological pathology, and obesity, in addition to shock on admission and consolidations on X-rays. Objetivo: Caracterizar el comportamiento de COVID-19 en niños chilenos hospitalizados en unidades de paciente crítico pediátrico (UPCP) y evaluar factores de riesgo para COVID-19 severo.Pacientes y Método: Estudio multicéntrico cohorte prospectivo, pacientes 0-18 años con SARS-CoV-2 confirmado hospitalizados en UPCP. Se registraron variables clínicas, laboratorio, imagenológicas y terapéuticas. Se comparó “COVID-19 leve/moderado” versus “COVID-19 severo” utilizando mediana con rango intercuartil (RIC), test U Mann-Whitney, Test Fisher de dos colas y análisis multivariado binario forward para ajuste de variables para “COVID-19 severo”. Significativo p < 0,05.Resultados: 219 pacientes, 55,3% hombres, mediana edad 86 meses (RIC: 13,5-156). Comorbilidades principales: obesidad, enfermedades respiratorias. Mortalidad global: 3,6%. “COVID-19 severo” (26,5%) mostró más leucopenia, linfopenia, más inflamación y alteración de órganos (p < 0,05). También desarrolló más Sepsis/shock, SDRA y disfunción de órganos, requirió más terapia hemodinámica, antiinflamatoria, anticoagulación, antibioterapia, con mayor estadía en UPCP/hospitalaria (p < 0,05) y mortalidad de 13,8%. Factores de riesgo asociados a “COVID-19 severo”: shock al ingreso (aOR 28,44 [IC95%: 10,45-77,4]), obesidad (aOR 3,55 [IC95%: 1,3-9,6]), condensación (aOR 3,1 [IC95%: 1,1-8,7]), atelectasia (aOR: 8.7 [IC95%: 1,17-64,3]), corticoides dosis de estrés (aOR 7,7 [IC95%: 1,9-30,6]), antibioterapia precoz (aOR: 12,02 [IC95%: 1,11-130,02]), inmunodeficiencia adquirida/ congénita (aOR: 19,2 [IC95%: 1,19-321]) y patología oncológica (aOR: 10,7 [IC95%: 2,14-47,8]). Conclusión: En esta cohorte pediátrica chilena, el perfil de paciente que ingresó a UPCP fue de sexo masculino en edad escolar con comorbilidad asociada. Factores de riesgo asociados a COVID-19 severo fueron: presencia de comorbilidades (inmunodeficiencia adquirida/congénita, patología oncológica y obesidad), shock al ingreso y condensaciones en las imágenes radiológicas.
Metadata
Show full item recordRelated items
Showing items related by title, author, creator and subject.
-
Teletrabajo y teleestudio en casa: percepciones de usuarios en tiempos de COVID-19: Percepções de usuários e observações espaciais em tempos de pandemia de COVID-19
Silva Loureiro, Priscilla; Fonseca de Campos, Paulo Eduardo. Revista de Arquitectura; Vol. 28 Núm. 45 (2023); 120-141 -
Childhood and COVID-19: The indirect effects of the COVID-19 pandemic on the well-being of children and adolescents
Díaz Rubio, Franco; Donoso Fuentes, Alejandro. Revista Chilena de Pediatría; Vol. 93, Núm. 1 (2022): Enero - Febrero; 10-18 -
O paradoxo do biopoder e a pandemia da COVID-19 na Amazônia: O caso de Manaus
Seabra, Vlamir Nascimento; Karnopp, Erica; Steyer, Maria Raquel Pilar. Política. Revista de Ciencia Política; Vol. 59 Núm. 1 (2021): Análisis de la política latinoamericana durante la pandemia; 35-57